Modeling Signal Propagation Mechanisms and Ligand-Based Conformational Dynamics of the Hsp90 Molecular Chaperone Full-Length Dimer

Hsp90 is a molecular chaperone essential for protein folding and activation in normal homeostasis and stress response. ATP binding and hydrolysis facilitate Hsp90 conformational changes required for client activation. Hsp90 plays an important role in disease states, particularly in cancer, where chaperoning of the mutated and overexpressed oncoproteins is important for function. Recent studies have illuminated mechanisms related to the chaperone function. However, an atomic resolution view of Hsp90 conformational dynamics, determined by the presence of different binding partners, is critical to define communication pathways between remote residues in different domains intimately affecting the chaperone cycle. Here, we present a computational analysis of signal propagation and long-range communication pathways in Hsp90. We carried out molecular dynamics simulations of the full-length Hsp90 dimer, combined with essential dynamics, correlation analysis, and a signal propagation model. All-atom MD simulations with timescales of 70 ns have been performed for complexes with the natural substrates ATP and ADP and for the unliganded dimer. We elucidate the mechanisms of signal propagation and determine “hot spots” involved in interdomain communication pathways from the nucleotide-binding site to the C-terminal domain interface. A comprehensive computational analysis of the Hsp90 communication pathways and dynamics at atomic resolution has revealed the role of the nucleotide in effecting conformational changes, elucidating the mechanisms of signal propagation. Functionally important residues and secondary structure elements emerge as effective mediators of communication between the nucleotide-binding site and the C-terminal interface. Furthermore, we show that specific interdomain signal propagation pathways may be activated as a function of the ligand. Our results support a “conformational selection model” of the Hsp90 mechanism, whereby the protein may exist in a dynamic equilibrium between different conformational states available on the energy landscape and binding of a specific partner can bias the equilibrium toward functionally relevant complexes.

[1]  I. Bahar,et al.  Gaussian Dynamics of Folded Proteins , 1997 .

[2]  Oliver F. Lange,et al.  Recognition Dynamics Up to Microseconds Revealed from an RDC-Derived Ubiquitin Ensemble in Solution , 2008, Science.

[3]  Amos Maritan,et al.  Elastic properties of proteins: insight on the folding process and evolutionary selection of native structures. , 2002, Journal of molecular biology.

[4]  Mark A. Wilson,et al.  Intrinsic motions along an enzymatic reaction trajectory , 2007, Nature.

[5]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[6]  H. Berendsen,et al.  Essential dynamics of proteins , 1993, Proteins.

[7]  Chrisostomos Prodromou,et al.  Sensitivity to Hsp90-targeting drugs can arise with mutation to the Hsp90 chaperone, cochaperones and plasma membrane ATP binding cassette transporters of yeast. , 2003, European journal of biochemistry.

[8]  Xavier Barril,et al.  4-Amino derivatives of the Hsp90 inhibitor CCT018159. , 2006, Bioorganic & medicinal chemistry letters.

[9]  S. Lindquist,et al.  HSP90 and the chaperoning of cancer , 2005, Nature Reviews Cancer.

[10]  L. Neckers,et al.  Heat shock protein 90 as a molecular target for cancer therapeutics. , 2003, Cancer cell.

[11]  Johannes Buchner,et al.  The ATPase Cycle of the Endoplasmic Chaperone Grp94* , 2007, Journal of Biological Chemistry.

[12]  T. Straatsma,et al.  THE MISSING TERM IN EFFECTIVE PAIR POTENTIALS , 1987 .

[13]  L. Neckers,et al.  Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins. , 2000, Journal of the National Cancer Institute.

[14]  G. Clore,et al.  Open-to-closed transition in apo maltose-binding protein observed by paramagnetic NMR , 2007, Nature.

[15]  Cam Patterson,et al.  The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. , 2007, The Journal of clinical investigation.

[16]  David A Agard,et al.  Species-dependent ensembles of conserved conformational states define the Hsp90 chaperone ATPase cycle. , 2008, Molecular cell.

[17]  M. Karplus,et al.  Collective motions in proteins: A covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations , 1991, Proteins.

[18]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997 .

[19]  David A. Agard,et al.  Intra- and Intermonomer Interactions Are Required to Synergistically Facilitate ATP Hydrolysis in Hsp90*S⃞♦ , 2008, Journal of Biological Chemistry.

[20]  Jason C. Young,et al.  Pathways of chaperone-mediated protein folding in the cytosol , 2004, Nature Reviews Molecular Cell Biology.

[21]  Hwa-Young Kim,et al.  Structures of the N-terminal and middle domains of E. coli Hsp90 and conformation changes upon ADP binding. , 2005, Structure.

[22]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..

[23]  Chrisostomos Prodromou,et al.  Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)‐domain co‐chaperones , 1999, The EMBO journal.

[24]  B. Halle,et al.  Flexibility and packing in proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Pearl,et al.  Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. , 1999, Journal of medicinal chemistry.

[26]  L. Neckers,et al.  The Heat Shock Protein 90 Antagonist Novobiocin Interacts with a Previously Unrecognized ATP-binding Domain in the Carboxyl Terminus of the Chaperone* , 2000, The Journal of Biological Chemistry.

[27]  Nathan A. Baker,et al.  Molecular dynamics simulation of the Escherichia coli NikR protein: equilibrium conformational fluctuations reveal interdomain allosteric communication pathways. , 2008, Journal of molecular biology.

[28]  H Frauenfelder,et al.  Dynamics of ligand binding to myoglobin. , 1975, Biochemistry.

[29]  Andrew Emili,et al.  Navigating the Chaperone Network: An Integrative Map of Physical and Genetic Interactions Mediated by the Hsp90 Chaperone , 2005, Cell.

[30]  Andrew E. Torda,et al.  The GROMOS biomolecular simulation program package , 1999 .

[31]  Gabriela Chiosis,et al.  Structural and quantum chemical studies of 8-aryl-sulfanyl adenine class Hsp90 inhibitors. , 2006, Journal of medicinal chemistry.

[32]  Jill L. Johnson,et al.  Nucleotide-Dependent Interaction of Saccharomyces cerevisiae Hsp90 with the Cochaperone Proteins Sti1, Cpr6, and Sba1 , 2006, Molecular and Cellular Biology.

[33]  Alessandra Villa,et al.  Incorporating the effect of ionic strength in free energy calculations using explicit ions , 2005, J. Comput. Chem..

[34]  X. Daura,et al.  Reversible peptide folding in solution by molecular dynamics simulation. , 1998, Journal of molecular biology.

[35]  L. Kay,et al.  Intrinsic dynamics of an enzyme underlies catalysis , 2005, Nature.

[36]  Jie Ge,et al.  Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90 , 2006, Proceedings of the National Academy of Sciences.

[37]  Paul Workman,et al.  Activation of the ATPase activity of hsp90 by the stress-regulated cochaperone aha1. , 2002, Molecular cell.

[38]  Peter G Wolynes,et al.  Localizing frustration in native proteins and protein assemblies , 2007, Proceedings of the National Academy of Sciences.

[39]  Laurence H. Pearl,et al.  A molecular clamp in the crystal structure of the N-terminal domain of the yeast Hsp90 chaperone , 1997, Nature Structural Biology.

[40]  R. Buey,et al.  Apo‐Hsp90 coexists in two open conformational states in solution , 2008, Biology of the cell.

[41]  D. Agard,et al.  The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site. , 2004, Structure.

[42]  Harald Schwalbe,et al.  The Human Cdc37·Hsp90 Complex Studied by Heteronuclear NMR Spectroscopy* , 2009, Journal of Biological Chemistry.

[43]  Gurmeet Kaur,et al.  Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin , 2004, Clinical Cancer Research.

[44]  L. Pearl,et al.  The Hsp90 molecular chaperone: an open and shut case for treatment. , 2008, The Biochemical journal.

[45]  Friedrich Förster,et al.  Multiple conformations of E. coli Hsp90 in solution: insights into the conformational dynamics of Hsp90. , 2008, Structure.

[46]  C. Micheletti,et al.  Structural and dynamical alignment of enzymes with partial structural similarity , 2007 .

[47]  Paul Workman,et al.  Overview: translating Hsp90 biology into Hsp90 drugs. , 2003, Current cancer drug targets.

[48]  David A. Agard,et al.  Structural Analysis of E. coli hsp90 Reveals Dramatic Nucleotide-Dependent Conformational Rearrangements , 2006, Cell.

[49]  L. Pearl,et al.  A common conformationally coupled ATPase mechanism for yeast and human cytoplasmic HSP90s , 2009, The FEBS journal.

[50]  Giulio Rastelli,et al.  Crystal structure and molecular modeling of 17-DMAG in complex with human Hsp90. , 2003, Chemistry & biology.

[51]  C. Chennubhotla,et al.  Coupling between global dynamics and signal transduction pathways: a mechanism of allostery for chaperonin GroEL. , 2008, Molecular bioSystems.

[52]  C Micheletti,et al.  Anharmonicity and self-similarity of the free energy landscape of protein G. , 2006, Physical review letters.

[53]  Martin Karplus,et al.  Large amplitude conformational change in proteins explored with a plastic network model: adenylate kinase. , 2005, Journal of molecular biology.

[54]  Marco Siderius,et al.  The Middle Domain of Hsp90 Acts as a Discriminator between Different Types of Client Proteins , 2006, Molecular and Cellular Biology.

[55]  P. Kollman,et al.  Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models , 1992 .

[56]  H Frauenfelder,et al.  Myoglobin: The hydrogen atom of biology and a paradigm of complexity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Jackson,et al.  Structural studies on the co-chaperone Hop and its complexes with Hsp90. , 2008, Journal of molecular biology.

[58]  Nicholas J. Hoogenraad,et al.  Molecular Chaperones Hsp90 and Hsp70 Deliver Preproteins to the Mitochondrial Import Receptor Tom70 , 2003, Cell.

[59]  Wei Zhang,et al.  Biochemical and structural studies of the interaction of Cdc37 with Hsp90. , 2004, Journal of molecular biology.

[60]  D. Mok,et al.  Modulation of Chaperone Function and Cochaperone Interaction by Novobiocin in the C-terminal Domain of Hsp90 , 2006, Journal of Biological Chemistry.

[61]  L. Pearl,et al.  Crystal structure of an Hsp90–nucleotide–p23/Sba1 closed chaperone complex , 2006, Nature.

[62]  Chrisostomos Prodromou,et al.  Structural and functional analysis of the middle segment of hsp90: implications for ATP hydrolysis and client protein and cochaperone interactions. , 2003, Molecular cell.

[63]  K. Schulten,et al.  Mechanism of signal propagation upon retinal isomerization: insights from molecular dynamics simulations of rhodopsin restrained by normal modes. , 2008, Biophysical journal.

[64]  A. Atilgan,et al.  Direct evaluation of thermal fluctuations in proteins using a single-parameter harmonic potential. , 1997, Folding & design.

[65]  S. Lindquist,et al.  Mutational analysis of Hsp90 function: interactions with a steroid receptor and a protein kinase , 1995, Molecular and cellular biology.

[66]  M. Gerstein,et al.  Diverse Cellular Functions of the Hsp90 Molecular Chaperone Uncovered Using Systems Approaches , 2007, Cell.

[67]  Wei Zhang,et al.  Conformational dynamics of the molecular chaperone Hsp90 in complexes with a co-chaperone and anticancer drugs. , 2007, Journal of molecular biology.

[68]  M. Karplus,et al.  A hierarchy of timescales in protein dynamics is linked to enzyme catalysis , 2007, Nature.

[69]  Jill L Johnson,et al.  Definition of the minimal fragments of Sti1 required for dimerization, interaction with Hsp70 and Hsp90 and in vivo functions. , 2007, The Biochemical journal.

[70]  Chrisostomos Prodromou,et al.  The ATPase cycle of Hsp90 drives a molecular ‘clamp’ via transient dimerization of the N‐terminal domains , 2000, The EMBO journal.

[71]  R. Immormino,et al.  Structures of GRP94-nucleotide complexes reveal mechanistic differences between the hsp90 chaperones. , 2007, Molecular cell.

[72]  A. Sali,et al.  Modeling of loops in protein structures , 2000, Protein science : a publication of the Protein Society.

[73]  Charles L Brooks,et al.  Coevolution of function and the folding landscape: correlation with density of native contacts. , 2008, Biophysical journal.

[74]  Jason C. Young,et al.  Hsp90: a specialized but essential protein-folding tool. , 2001, The Journal of cell biology.

[75]  Dan S. Tawfik,et al.  Antibody Multispecificity Mediated by Conformational Diversity , 2003, Science.

[76]  L. Pearl,et al.  Structure and mechanism of the Hsp90 molecular chaperone machinery. , 2006, Annual review of biochemistry.

[77]  R. Immormino,et al.  Ligand-induced Conformational Shift in the N-terminal Domain of GRP94, an Hsp90 Chaperone* , 2004, Journal of Biological Chemistry.

[78]  L. Neckers,et al.  Heat shock protein 90: The cancer chaperone , 2007, Journal of Biosciences.

[79]  P. Wolynes,et al.  The energy landscapes and motions of proteins. , 1991, Science.

[80]  Giorgio Colombo,et al.  Understanding ligand-based modulation of the Hsp90 molecular chaperone dynamics at atomic resolution , 2008, Proceedings of the National Academy of Sciences.

[81]  R. Immormino,et al.  Structure of Unliganded GRP94, the Endoplasmic Reticulum Hsp90 , 2005, Journal of Biological Chemistry.